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We have previously reported that the peroxisomal ~-oxidation system for very long chain fatty acids is de- 
fective in X-linked childhood adrenoleukodystrophy [(1984) Proc. Natl. Acad. Sci. USA 81, 4203-42073. 
In order to elucidate the specific enzyme defect, we examined the oxidation of [I-%]lignoceric acid, 
[ I-%]lignoceroyl-CoA and (1-I%)-labelled a&unsaturated 1ignoceroylCoA (substrates for the lst, 2nd, 
and 3rd steps of the #?-oxidation cycle, respectively). These studies suggest hat the pathognomonic accumu- 
lation of very long chain fatty acids in X-linked childhood ALD may be due to the defective activity of 
peroxisomal very long chain (lignoceroyl-CoA) acyl-CoA ligase. 
Adrenoleukodystrophy Peroxisome Fatty acid j%Oxidation 
L~gnoceroy~-~0A &se 
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1. INTRODUCTION 
X-linked adrenoleukodystrophy (ALD) is a 
childhood disorder characterized by progressive 
demyelination and impaired function of the 
adrenal cortex [l]. It is associated with the 
pathognomonic accumulation of cholesterol esters 
of saturated very long chain (VLC) fatty acids 
(> Cz2) in the brain and adrenals [2]. In other 
tissues the accumulation of VLC fatty acids is 
found in glycerolipids and sphingolipids [3]. Other 
forms of ALD include adrenomyeloneuropathy 
(AMN) and ALD (autosomal recessive). Although 
accumulation of VLC fatty acids is the observed 
hallmark in all forms of ALD, the childhood form 
differs from the neonatal in that peroxisomes are 
present in the liver of childhood ALD whereas they 
are very much reduced in size and number in the 
neonatal ALD [4]. Due to the excessive accumula- 
The following desginations are used: palmitic acid, n- 
hexadecanoic acid; lignoceric acid, n-tetracosanoic acid; 
cY&unsaturated lignoceric acid, n-tetracosenoic acid 
tion of VLC fatty acids in the cholesterol ester 
fraction, initial studies to delineate the specific en- 
zyme defect focused on the metabolism of 
cholesterol esters. However, no defect in ALD was 
observed (5,6]. Studies of normal cholesterol ester 
metabolism and the accumulation of VLC fatty 
acids in lipids other than cholesterol esters sug- 
gested that the defect in childhood ALD may be in 
the metabolism of VLC fatty acids. Tsuji et al. [7] 
reported an increased rate of chain elongation in 
ALD fibroblasts as compared to normal cells. 
These findings suggested that the defect in ALD 
may be in the synthesis of VLC fatty acids. 
However, the excessive accumulation of VCL fatty 
acids in ALD fibroblasts as compared to control 
cells when [l-‘4C]lignoceric acid 181 and [1-r4C]- 
cerotic acid [9] were incubated with fibroblast 
cultures indicated that catabolism of these fatty 
acids could be defective. 
We examined the degradation of fatty acids of 
different chain lengths (c16-c26) and reported that 
the cause of excessive accumulation of VLC fatty 
acids in ALD may be in the degradation of VLC 
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(C24,C26) fatty acids whereas oxidation of palmitic 
acid (Cl,) was normal [ 10-121. The studies of Jaffe 
et al. [13] and Rizzo et al. [14] also demonstrated 
a defect in the degradation of VLC fatty acids in 
ALD. Although it is not known whether both syn- 
thesis and degradation of VLC fatty acids are im- 
paired in ALD, a defect in degradation of VLC 
fatty acids has been confirmed in 4 different 
laboratories [8-141. This study was undertaken to 
delineate the specific enzymatic step of the p- 
oxidation system which may be impaired in X- 
linked childhood ALD. 
2. MATERIALS AND METHODS 
2.1. Materials 
Malate, FAD, NAD, L-carnitine and a-cyclo- 
dextrin were purchased from Sigma, St. Louis, 
MO. ATP and CoASH were obtained from PL- 
Biochemicals, Milwaukee, WI. [l-‘4C]Palmitic 
acids and Ki4CN were purchased from New 
England Nuclear, Boston, MA. 
2.2. Synthesis of substrates 
[1-r4C]Lignoceric acid was synthesized from 
Kr4CN and tricosanoyl bromide [ 151. (l-14C)- 
labeled ad-unsaturated lignoceric acid was syn- 
thesized from [l-14C]lignoceric acid by LY- 
bromination followed by dehydrobromination 
[ 161. [ 1 -‘4C]Lignoceroyl-CoA and cu$-unsaturated 
lignoceroyl-CoA were prepared as in [ 171. 
2.3. Cell cultures 
Fibroblast cell lines from X-linked childhood 
ALD patients and controls were grown in a 5% 
CO2 atmosphere at 37°C in Dulbecco’s modified 
Eagle’s minimum essential medium supplemented 
with 15% fetal calf serum. Cells were harvested 
3-4 days after confluence by trypsinization and the 
cell pellets washed 3 times with Hank’s balanced 
salt solution. 
2.4. Enzyme assay 
Enzyme activity for oxidation of ( 1-r4C)-labeled 
fatty acids to acetate (water-soluble product) was 
measured as described [12]. Briefly, the reaction 
mixture (0.5 ml) contained 12 PM (l-‘4C)-labeled 
fatty acid coated on celite [l 11, 20 mM Mops-HCl 
buffer, pH 7.9, 30 mM KCI, 1 mM MgC12, 
8.5 mM ATP, 0.25 mM NAD, 0.17 mM FAD, 
2.5 mM L-carnitine, 0.08 mM CoASH, and 1 mg 
a-cyclodextrin. Cells were homogenized by 20 
passes with a hand-driven teflon-coated homo- 
genizer in 0.06% NaCl. The reaction was started 
by the addition of enzyme and stopped with 0.5 ml 
ice-cold 0.6 N perchloric acid. The supernatant 
fraction was transferred to another tube, parti- 
tioned by the procedure of Folch et al. [ 181, and 
the radioactivity in the upper layer measured. The 
amount of radioactivity is an index of the amount 
of (l-14C)-labeled fatty acid oxidized to acetate. 
Protein was measured by the procedure of Brad- 
ford [19]. 
3. RESULTS AND DISCUSSION 
Fatty acid ,&-oxidation takes place in both mito- 
chondria and peroxisomes. Palmitic acid is oxi- 
dized in mitochondria at 3-5-times the rate of that 
in peroxisomes [20-221 whereas lignoceric acid is 
mostly and possibly exclusively oxidized in per- 
oxisomes [12]. Our previous studies of childhood 
ALD demonstrated that peroxisomal P-oxidation 
of palmitic acid is normal but that of lignoceric 
acid is defective [ 10-121. Since peroxisomes in 
childhood ALD are normal in size and number, a 
specific enzyme defect is suggested [12]. The 
peroxisomalfl-oxidation enzyme system consists of 
a sequence of 5 steps: (1) activation by acyl-CoA 
ligase; (2) a,,&unsaturation by acyl-CoA oxidase; 
(3) hydration by acyl-CoA hydratase; (4) 
dehydrogenation by ,&hydroxyacyl-CoA dehydro- 
genase and (5) formation of acetate by P-ketoacyl- 
CoA thiolase. To elucidate the specific enzyme 
defect we synthesized [l-‘4C]lignoceric acid, 
[I-r4C]lignoceroyl-CoA, (l-‘4C)-labeled a#- 
unsaturated lignoceroyl-CoA and examined their 
rate of oxidation as described [12]. Since the pro- 
cedure for isolation of peroxisomes from cultured 
fibroblasts has not yet been developed, these 
studies were performed with total cellular 
homogenates. In agreement with our previous 
studies [lo-121 and others [8,9,13,14], there was 
no difference in the oxidation of palmitic acid be- 
tween ALD and control fibroblasts. However, the 
degradation of [ l-‘4C]lignoceric acid to water- 
soluble product (acetate) in ALD was 32% of con- 
trol fibroblasts (table 1). The ratio of the relative 
rate of degradation of palmitic acid to lignoceric 
acid was 3.18-times higher for ALD than the con- 
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trol (table 2). When the acyl-CoA derivative was 
Table 1 
Oxidation of (l-14C)-labeled fatty acids and their acyl-CoA derivatives 
Control (mean f SE) Childhood ALD (mean f SE) 
Palmitic acid 88534 + 6548 95027 k 8026 (p = 0.634) 
Palmitoyl-CoA 229427 f 10263 238938 f 13694 @ = 0.148) 
Lignoceroyl acid 10242 + 586 3255 + 439 (p < 0.001) 
Lignoceroyl-CoA 41530 f 3708 44853 + 8243 @ = 0.585) 
a&unsaturated 
lignoceroyl-CoA 77237 f 13927 76881 f 11889 @ = 0.568) 
The )oxidation of (1-r4C)-labeled fatty acids and their acyl-CoA derivatives in 
homogenates of control and ALD cultured skin fibroblasts was measured as cpm 
water-soluble product/mg protein per h 
used as the substrate (substrate for the 2nd step of 
the P-oxidation cycle) the oxidation of both 
[ 1-14C]lignoceroyl-CoA and [ 1 -14C]palmitoyl-CoA 
was normal (table 1). Therefore, the ratios of 
relative rates of oxidation of palmitoyl-CoA to 
1ignoceroylXoA in ALD and control were 5.12 
and 5.7, respectively (table 2). These results sug- 
gest that the defect in childhood ALD is in the 1st 
step of the&oxidation cycle, which is activation of 
VLC fatty acids to their acyl-CoA derivatives. 
Moreover, a&unsaturated lignoceroyl-CoA, the 
substrate for the 3rd step of &oxidation, was also 
oxidized normally in fibroblasts from childhood 
ALD (table 1). Since substrates for the 2nd and 3rd 
step of the &oxidation cycle are metabolized nor- 
mally, the enzymes for the 4th step, ,&hydroxy- 
acyl-CoA dehydrogenase, and 5th step, thiolase, 
are normal. The ratios of the oxidation of pal- 
mitoyl-CoA to a&-unsaturated lignoceroyl-CoA 
were 3.16 and 3.13 for ALD and control 
fibroblasts, respectively (table 2). The ratios for 
the oxidation of lignoceroyl-CoA to cu&un- 
saturated lignoceroyl-CoA were also the same for 
both ALD and control (table 2). Fatty acid fl- 
oxidation is a series of 5 steps in sequence. Our 
results indicate that activation of lignoceric acid by 
acyl-CoA ligase, the 1st step in the &oxidation se- 
quence, is defective while lignoceroyl-CoA and 
a&unsaturated lignoceroyl-CoA, the substrates 
for the 2nd and 3rd steps, are degraded normally. 
This identifies lignoceroyl-CoA ligase as the en- 
zyme impaired in childhood ALD. 
At the subcellular level, palmitoyl-CoA ligase 
activity is known to be present in mitochondria, 
microsomes and peroxisomes [23-251. Ligno- 
ceroyl-CoA ligase activity has also been demon- 
strated in microsomal [26] and mitochondrial 
peroxisomal fractions (Singh et al., unpublished). 
Peroxisomes isolated from human liver contain 
only 16% palmitoyl-CoA ligase activity, while 21 
and 60% of this enzyme activity was localized in 
mitochondrial and microsomal fractions, respec- 
tively [27]. Therefore, direct measurements of 
lignoceroyl-CoA ligase activity in the homogenates 
of fibroblasts did not show any significant dif- 
ferences between ALD and controls, (50.3 and 
42.8 pmol/mg protein per 5 min for control and 
Table 2 
Relative rates of oxidation of fatty acids and their acyl-CoA derivatives in homogenates of control and ALD fibroblasts 
[ l-‘4C]Palmitic acid/[l-‘4C]lignoceric acid 
[ l-14C]Palmitoyl-CoA/[1-‘4C]lignoceroyl-CoA 
[ l-‘4C]Palmitoyl-CoA/(l-‘4C)-labeled cY&unsaturated lignoceroyl-CoA 
[l-‘4C]Lignoceroyl-CoA/(1-‘4C)-labeled cu,@unsaturated lignoceroyl-CoA 
Childhood ALD Control 
(mean f SE) (mean + SE) 
27.24 f 2.65 8.57 f 1.15 
5.12 + 0.5 5.7 f 0.67 
3.16 + 0.36 3.13 f 0.5 
0.61 f 0.12 0.57 + 0.07 
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ALD, respectively). Since lignoceric acid is oxi- 
dized mostly and possibly exclusively in peroxi- 
somes [12], the impaired oxidation of lignoceric 
acid as compared to normal activity with ligno- 
ceroyl-CoA in ALD fibroblasts (tables 1 and 2) 
therefore clearly demonstrates that activation of 
lignoceric acid to lignoceroyl-CoA is defective in 
childhood ALD. Palmitoyl-CoA and lignoceroyl- 
CoA are synthesized by two different enzymes in 
microsomal membranes [28]. Our previous studies 
suggested that in peroxisomes there may be two 
different fatty acid &oxidation enzyme systems 
(one for palmitic acid and the other for lignoceric 
acid [12]). Therefore, it may be possible that 
peroxisomes like microsomal membranes [28] also 
have different enzymes for the synthesis of lig- 
noceroyl-CoA and palmitoyl-CoA and that syn- 
thesis of lignoceroyl-CoA by peroxisomal lig- 
noceroyl-CoA ligase is impaired in childhood 
ALD. 
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